These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 16474259)

  • 1. Oral amphotericin B for the prevention of Candida bloodstream infection in critically ill children.
    Ben-Ari J; Samra Z; Nahum E; Levy I; Ashkenazi S; Schonfeld TM
    Pediatr Crit Care Med; 2006 Mar; 7(2):115-8. PubMed ID: 16474259
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Candidal bloodstream infection: will prevention work?
    Lum LC
    Pediatr Crit Care Med; 2006 Mar; 7(2):184-5. PubMed ID: 16531952
    [No Abstract]   [Full Text] [Related]  

  • 3. The epidemiology of Candida colonization and invasive candidiasis in a surgical intensive care unit where fluconazole prophylaxis is utilized: follow-up to a randomized clinical trial.
    Magill SS; Swoboda SM; Shields CE; Colantuoni EA; Fothergill AW; Merz WG; Lipsett PA; Hendrix CW
    Ann Surg; 2009 Apr; 249(4):657-65. PubMed ID: 19300221
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic intervention to reduce central line-associated bloodstream infection rates in a pediatric cardiac intensive care unit.
    Costello JM; Morrow DF; Graham DA; Potter-Bynoe G; Sandora TJ; Laussen PC
    Pediatrics; 2008 May; 121(5):915-23. PubMed ID: 18450894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia.
    Shorr AF; Lazarus DR; Sherner JH; Jackson WL; Morrel M; Fraser VJ; Kollef MH
    Crit Care Med; 2007 Apr; 35(4):1077-83. PubMed ID: 17312565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epidemiology, management, and risk factors for death of invasive Candida infections in critical care: a multicenter, prospective, observational study in France (2005-2006).
    Leroy O; Gangneux JP; Montravers P; Mira JP; Gouin F; Sollet JP; Carlet J; Reynes J; Rosenheim M; Regnier B; Lortholary O;
    Crit Care Med; 2009 May; 37(5):1612-8. PubMed ID: 19325476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanically ventilated pediatric stem cell transplant recipients: effect of cord blood transplant and organ dysfunction on outcome.
    Hagen SA; Craig DM; Martin PL; Plumer DD; Gentile MA; Schulman SR; Cheifetz IM
    Pediatr Crit Care Med; 2003 Apr; 4(2):206-13. PubMed ID: 12749654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extubation failure in pediatric intensive care incidence and outcomes.
    Baisch SD; Wheeler WB; Kurachek SC; Cornfield DN
    Pediatr Crit Care Med; 2005 May; 6(3):312-8. PubMed ID: 15857531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Epidemiological features of Candida infections detected in intensive care units and risk factors affecting mortality].
    Acar A; Oncül O; Küçükardali Y; Ozyurt M; Haznedaroğlu T; Cavuşlu S
    Mikrobiyol Bul; 2008 Jul; 42(3):451-61. PubMed ID: 18822889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bloodstream infections due to Candida species in the intensive care unit: identifying especially high-risk patients to determine prevention strategies.
    Wenzel RP; Gennings C
    Clin Infect Dis; 2005 Sep; 41 Suppl 6():S389-93. PubMed ID: 16108005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Short-course amphotericin B therapy for candidemia in pediatric patients.
    Donowitz LG; Hendley JO
    Pediatrics; 1995 Jun; 95(6):888-91. PubMed ID: 7761216
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk factors for Candida infections in a neonatal intensive care unit in Costa Rica.
    Avila-Aguero ML; Canas-Coto A; Ulloa-Gutierrez R; Caro MA; Alfaro B; Paris MM
    Int J Infect Dis; 2005 Mar; 9(2):90-5. PubMed ID: 15708324
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk factors associated with candidaemia in the neonatal intensive care unit: a case-control study.
    Linder N; Levit O; Klinger G; Kogan I; Levy I; Shalit I; Ashkenazi S; Sirota L
    J Hosp Infect; 2004 Aug; 57(4):321-4. PubMed ID: 15262393
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of antifungals in the surgical intensive care unit: a multi-institutional study.
    Garey KW; Neuhauser MM; Bearden DT; Cannon JP; Lewis RE; Gentry LO; Kontoyiannis DP
    Mycoses; 2006 May; 49(3):226-31. PubMed ID: 16681815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Randomized comparison between fluconazole and itraconazole for the treatment of candidemia in a pediatric intensive care unit: a preliminary study.
    Mondal RK; Singhi SC; Chakrabarti A; M J
    Pediatr Crit Care Med; 2004 Nov; 5(6):561-5. PubMed ID: 15530193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National epidemiology of mycoses survey (NEMIS): variations in rates of bloodstream infections due to Candida species in seven surgical intensive care units and six neonatal intensive care units.
    Rangel-Frausto MS; Wiblin T; Blumberg HM; Saiman L; Patterson J; Rinaldi M; Pfaller M; Edwards JE; Jarvis W; Dawson J; Wenzel RP
    Clin Infect Dis; 1999 Aug; 29(2):253-8. PubMed ID: 10476721
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of candidaemia and relationship with fluconazole use in an intensive care unit.
    Bassetti M; Ansaldi F; Nicolini L; Malfatto E; Molinari MP; Mussap M; Rebesco B; Bobbio Pallavicini F; Icardi G; Viscoli C
    J Antimicrob Chemother; 2009 Sep; 64(3):625-9. PubMed ID: 19622536
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug use density in critically ill children and newborns: analysis of various methodologies.
    Valcourt K; Norozian F; Lee H; Raszynski A; Torbati D; Totapally BR
    Pediatr Crit Care Med; 2009 Jul; 10(4):495-9. PubMed ID: 19451853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Candida albicans versus non-albicans intensive care unit-acquired bloodstream infections: differences in risk factors and outcome.
    Dimopoulos G; Ntziora F; Rachiotis G; Armaganidis A; Falagas ME
    Anesth Analg; 2008 Feb; 106(2):523-9, table of contents. PubMed ID: 18227310
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low-dose amphotericin for prevention of serious fungal infection following liver transplantation.
    Shah T; Lai WK; Gow P; Leeming J; Mutimer D
    Transpl Infect Dis; 2005; 7(3-4):126-32. PubMed ID: 16390401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.